WASHINGTON, May 29, 2012 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that Mihael H. Polymeropoulos, M.D., Vanda's President and CEO, will deliver a corporate presentation at the Jefferies Global Healthcare Conference in New York City on Monday, June 4, 2012 at 12:30 p.m. Eastern Time.
Dr. Polymeropoulos' presentation at the Jefferies Global Healthcare Conference will be available live on Vanda's corporate website, where it also will be archived for 30 days. To access the presentation, go to Vanda's website at http://www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentation.
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.
Company Contact: Cristina Murphy Senior Communications Manager Vanda Pharmaceuticals Inc. (202) 734-3414 firstname.lastname@example.org
SOURCE Vanda Pharmaceuticals Inc.